15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells - PubMed (original) (raw)

doi: 10.1254/jphs.10001sc. Epub 2010 Apr 16.

Affiliations

• PMID: 20424389
• DOI: 10.1254/jphs.10001sc

Free article

15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells

Michiyoshi Hatanaka et al. J Pharmacol Sci. 2010.

Free article

Abstract

The chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells (CRTH2) is the most recently identified prostaglandin (PG) receptor for both PGD(2) and 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)). We examined the mechanism by which 15d-PGJ(2) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. CAY10471 (CRTH2 antagonist) inhibited both the neurite-promotion and p38 mitogen-activated protein (MAP) kinase phosphorylation induced by 15d-PGJ(2). In contrast, 13,14-dihydro-15-keto-PGD(2 )(DK-PGD(2)) (selective CRTH2 agonist) stimulated its phosphorylation but failed to produce neurite-promoting effects. These suggest, for the first time, the action of 15d-PGJ(2) is mediated by CRTH2, although the CRTH2 activation alone is insufficient for the underlying action.

PubMed Disclaimer

Similar articles

• Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2.
  Jung KM, Park KS, Oh JH, Jung SY, Yang KH, Song YS, Son DJ, Park YH, Yun YP, Lee MK, Oh KW, Hong JT. Jung KM, et al. Mol Pharmacol. 2003 Mar;63(3):607-16. doi: 10.1124/mol.63.3.607. Mol Pharmacol. 2003. PMID: 12606768
• CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.
  Sugimoto H, Shichijo M, Okano M, Bacon KB. Sugimoto H, et al. Eur J Pharmacol. 2005 Nov 7;524(1-3):30-7. doi: 10.1016/j.ejphar.2005.09.005. Epub 2005 Oct 27. Eur J Pharmacol. 2005. PMID: 16256979
• Induction of apoptosis in non-small cell lung carcinoma A549 cells by PGD₂ metabolite, 15d-PGJ₂.
  Wang JJ, Mak OT. Wang JJ, et al. Cell Biol Int. 2011 Nov;35(11):1089-96. doi: 10.1042/CBI20110707. Cell Biol Int. 2011. PMID: 21999315
• Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
  Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J. Ueki S, et al. Int Arch Allergy Immunol. 2007;143 Suppl 1:15-22. doi: 10.1159/000101399. Epub 2007 May 1. Int Arch Allergy Immunol. 2007. PMID: 17541271 Review.
• Antagonists of the prostaglandin D2 receptor CRTH2.
  Pettipher R, Hansel TT. Pettipher R, et al. Drug News Perspect. 2008 Jul-Aug;21(6):317-22. doi: 10.1358/dnp.2008.21.6.1246831. Drug News Perspect. 2008. PMID: 18836589 Review.

Cited by

• The therapeutic potential of CRTH2/DP2 beyond allergy and asthma.
  Jandl K, Heinemann A. Jandl K, et al. Prostaglandins Other Lipid Mediat. 2017 Nov;133:42-48. doi: 10.1016/j.prostaglandins.2017.08.006. Epub 2017 Aug 14. Prostaglandins Other Lipid Mediat. 2017. PMID: 28818625 Free PMC article. Review.
• Lipocalin-type prostaglandin D synthase regulates light-induced phase advance of the central circadian rhythm in mice.
  Kawaguchi C, Shintani N, Hayata-Takano A, Hatanaka M, Kuromi A, Nakamura R, Yamano Y, Shintani Y, Nagai K, Tsuchiya S, Sugimoto Y, Ichikawa A, Okuno Y, Urade Y, Hirai H, Nagata KY, Nakamura M, Narumiya S, Nakazawa T, Kasai A, Ago Y, Takuma K, Baba A, Hashimoto H. Kawaguchi C, et al. Commun Biol. 2020 Oct 8;3(1):557. doi: 10.1038/s42003-020-01281-w. Commun Biol. 2020. PMID: 33033338 Free PMC article.
• Identification of a prostaglandin D2 metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel.
  Shibata T, Takahashi K, Matsubara Y, Inuzuka E, Nakashima F, Takahashi N, Kozai D, Mori Y, Uchida K. Shibata T, et al. Sci Rep. 2016 Feb 16;6:21261. doi: 10.1038/srep21261. Sci Rep. 2016. PMID: 26879669 Free PMC article.
• Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model.
  Haba R, Shintani N, Onaka Y, Kanoh T, Wang H, Takenaga R, Hayata A, Hirai H, Nagata KY, Nakamura M, Kasai A, Hashimoto R, Nagayasu K, Nakazawa T, Hashimoto H, Baba A. Haba R, et al. J Neurosci. 2014 Feb 12;34(7):2514-23. doi: 10.1523/JNEUROSCI.1407-13.2014. J Neurosci. 2014. PMID: 24523542 Free PMC article.
• Activin A prevents neuron-like PC12 cell apoptosis after oxygen-glucose deprivation.
  Xu G, He J, Guo H, Mei C, Wang J, Li Z, Chen H, Mang J, Yang H, Xu Z. Xu G, et al. Neural Regen Res. 2013 Apr 15;8(11):1016-24. doi: 10.3969/j.issn.1673-5374.2013.11.007. Neural Regen Res. 2013. PMID: 25206395 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • J-STAGE, Japan Science and Technology Information Aggregator, Electronic
  • Medical Online, Meteo Inc

• Miscellaneous

  • NCI CPTAC Assay Portal